Physician profile
Mark D Suran
NPI 1548252364
$4,134.50
in general payments reported to CMS, 2019-2025
18 companies · $709 in 2025
The $709 reported for 2025 was more than what 80% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $331 · 2022: $308 · 2023: $864 · 2024: $1,691 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $526.30 | 2023-2025 | |
| Nevro Corp. | $397.61 | 2023-2024 | Senza |
| Smith+Nephew, INC. | $375.71 | 2020-2024 | Grafix Pl, Stravix Pl, Pico |
| Inari Medical, INC. | $306.25 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $277.05 | 2022-2024 | Nuzyra |
| Linvatec Corporation | $270.95 | 2024-2025 | Biobrace 23mm, Fracture and Correction Colag 2 |
| Horizon Therapeutics Plc | $245.25 | 2019-2020 | |
| Organogenesis INC. | $233.72 | 2023-2025 | Puraply Wound Matrix, Puraply Antimicrobial |
| Orthofix Medical, INC. | $224.97 | 2022-2023 | Physio-Stim |
| Amgen INC. | $218.20 | 2024 | |
| Cvrx, INC. | $178.39 | 2024 | Barostim Neo System |
| Biopro, INC. | $163.85 | 2023 | |
| Forma Medical | $146.66 | 2025 | Optimalmtp |
| Stryker Corporation | $134.94 | 2025 | Prostep Mica |
| Next Science LLC | $124.99 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $119.27 | 2023 | Fibergraft Aeridyan Matrix, Fibergraft Bg Morsels |
| Wright Medical Technology, INC. | $117.00 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $73.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Suran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.